spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Journal of Cell Science 115, e1901-e1901 (2002)
Copyright © 2002 The Company of Biologists Limited
doi:


In this issue

Metalloproteinase inhibitors


Metalloproteinases are secreted or cell surface proteases that degrade or proteolytically activate other cell surface molecules and components of the extracellular matrix (ECM). These enzymes are important for control of cell-cell and cell-ECM interactions during cell migration, differentiation and proliferation and are regulated by a number of inhibitors. In a Commentary on p. 3719, Gillian Murphy and co-workers review our understanding of these inhibitors, which include the tissue inhibitors of metalloproteinases (TIMPs), TIMP-like molecules such as netrins, {alpha}2 macroglobulin, and novel proteins such as RECK. TIMPs are ~21-kDa proteins that inhibit all known matrix metalloproteinases (MMPs). Not all of their effects appear to be due to inhibition of MMPs, however. TIMP2, for example, has mitogenic effects on erythroid precursor cells, acting through receptors linked to G proteins and cyclic AMP signalling. Similarly, the biological activities of RECK during angiogenesis probably extend beyond its ability to inhibit MMP-2, MMP-9 and MT1-MMP, and {alpha}2 macroglobulin might well do more than just inhibit endoproteinases. Murphy and co-workers suggest that only when these additional activities are fully understood will we be able to exploit the therapeutic potential of metalloproteinase inhibitors.


Related articles in JCS:

Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Andrew H. Baker, Dylan R. Edwards, and Gillian Murphy
JCS 2002 115: 3719-3727. [Abstract] [Full Text]  




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JCS
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content